← Back to Clinical Trials
Recruiting NCT06853405

NCT06853405 Nutrition-based Interventions to Prevent Cognitive Decline

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06853405
Status Recruiting
Phase
Sponsor Instituto de Saude Publica da Universidade do Porto
Condition Cognitive Dysfunction
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2025-01-27
Primary Completion 2026-05

Eligibility & Interventions

Sex All sexes
Min Age 55 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Nutrition-related lifestyle group sessionsCognitive trainingClinical nutrition consultations

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2025-01-27 with a primary completion date of 2026-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study intends to evaluate the feasibility and the effectiveness of an innovative and integrated nutrition-based intervention addressing key modifiable risk factors for dementia while meeting participants' preferences for nutrition-related sessions. The intervention will include lifestyle group sessions regarding nutrition education and physical activity, individualized cognitive training at home, as well as clinical nutrition consultations.

Eligibility Criteria

Inclusion Criteria: * Aged from 55 to 85 years old; * At least 4 years in the regular school system; * Higher individual risk for dementia defined as a score ≥6 points on the Cardiovascular Risk Factors, Aging and Dementia Dementia Risk Score (CAIDE). Exclusion Criteria: * Montreal Cognitive Assessment (MoCA) score lower than the validated cutoff points defined as 2 standard deviations below the normative reference value for the corresponding age and education in the Portuguese population; * Having a medical condition limiting the participation in the intervention (e.g., blindness, amputation…); * Lack of autonomy in daily activities; * Diagnosis of dementia or major incapacity.

Contact & Investigator

Central Contact

Daniela de Sousa, Master

✉ daniela.sousa@ispup.up.pt

📞 +351222061820

Frequently Asked Questions

Who can join the NCT06853405 clinical trial?

This trial is open to participants of all sexes, aged 55 Years or older, up to 85 Years, studying Cognitive Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06853405 currently recruiting?

Yes, NCT06853405 is actively recruiting participants. Contact the research team at daniela.sousa@ispup.up.pt for enrollment information.

Where is the NCT06853405 trial being conducted?

This trial is being conducted at Porto, Portugal, Porto, Portugal.

Who is sponsoring the NCT06853405 clinical trial?

NCT06853405 is sponsored by Instituto de Saude Publica da Universidade do Porto. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology